Derek J Maetzold, Pres. & Chief Exec. Officer at Castle Biosciences, sold CSTL on Sep 11, 2026
Data as of Oct 16
▼ SELL$2.3K71 shares at $32.78Derek J Maetzold Pres. & Chief Exec. OfficerCSTL Castle Biosciences Inc
- Traded
- Sep 11, 2026
- Disclosed
- Sep 15, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CSTL since disclosure
−10.0%
after the sale
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund
Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLDerek J Maetzold Pres. & Chief Exec. OfficerCSTL Castle Biosciences Inc$2.7Kdisclosed Sep 15 · filed 4 days after the trade
- ▼ SELLDerek J Maetzold Pres. & Chief Exec. OfficerCSTL Castle Biosciences Inc$85Kdisclosed Sep 15 · filed 4 days after the trade
- ▼ SELLDerek J Maetzold Pres. & Chief Exec. OfficerCSTL Castle Biosciences Inc$268Kdisclosed Sep 15 · filed 4 days after the trade
- ▼ SELLDerek J Maetzold Pres. & Chief Exec. OfficerCSTL Castle Biosciences Inc$100Kdisclosed Sep 15 · filed 4 days after the trade
- ▼ SELLDerek J Maetzold Pres. & Chief Exec. OfficerCSTL Castle Biosciences Inc$7.3Kdisclosed Sep 15 · filed 4 days after the trade